trict of Florida on Monday, March 3 refused to fully throw out a class-action suit implicating the company. Gilead, along with Bristol-Myers Squibb, Japan Tobacco, and Johnson & Johnson, have been accused of restricting competition in the HIV drug market, which is dominated by Gilead. [Continue Reading] ENVI

discount) (trading -4.9%) EFTA00329452 • Delta Lloyd: De Mol (who announced 3.02% stake yesterday) said to question RI amount (trading +7.2%) • Japan Tobacco FY16 ebit guidance 7% below consensus (fx headwinds) (out after the close) • Macquarie Group warns on key commodities and financial-markets busines

overnight following the stronger lead out of the US. Japan outperformed with the Nikkei closing at the highs as the JPY is trading back toward 105. Japan Tobacco lagged and closed -2.5% on reports that China may ban smoking in public places by year-end (weakness is spilling over to some of the tobacco names

6596 22% 6500 -20% Exporters Sumitomo Electric* 1540 NA 1772 15% 1638 -6% Exporters Toyota 5830 Buy 8000 37% 6100 -5% Exporters Japan Tobacco 3138 Buy 4200 34% 3440 -10% Exporters Hitachi* 770 NA 912.5 19% 752 2% Advertising Dentsu* 3755 NA 4309 15% 4200 -12% 25% -7.

6 22',S 6500 -.0.- Exporters Sum -terra Electric* 1540 NA 1772 15% 1638 -6% Exporters Thyote 5830 Buy 8000 37% 6100 -5% Exporters Japan Tobacco 3138 Buy 4200 34% 3440 -10% Exporters HItachIs 770 NA 912.5 19% 752 2% Advertising Dentsum 3755 NA 4309 15% 4200 -12% 25% -7.